NCT07870395 Voice-based Outcome Identification and Clinical Evaluation in Heart Failure
| NCT ID | NCT07870395 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Noah Labs |
| Condition | Heart Failure |
| Study Type | OBSERVATIONAL |
| Enrollment | 450 participants |
| Start Date | 2026-10-15 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 450 participants in total. It began in 2026-10-15 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
VOICE-HF is a clinical study designed to evaluate the performance of a novel non-invasive software device (Noah Labs Vox) that uses vocal characteristics to estimate DHF risk and has strong potential for clinical success. This study will compare the performance of Noah Labs Vox with the contemporary performance of commonly used weight-based remote monitoring rules and applications to determine efficacy and safety.
Eligibility Criteria
Inclusion Criteria: * Age ≥22 * HF diagnosis (Stage C) * DHF event within prior 180 days Exclusion Criteria: * Monitoring with implantable volume or pressure monitoring devices, or * Planned cardiac surgery or major intervention (e.g., LVAD or transplant), or * Otherwise inability or unwillingness to comply with study procedures.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07870395 clinical trial?
This trial is open to participants of all sexes, aged 22 Years or older, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07870395 currently recruiting?
Yes, NCT07870395 is actively recruiting participants. Contact the research team at leonhard.riehle@noah-labs.com for enrollment information.
Where is the NCT07870395 trial being conducted?
This trial is being conducted at Boston, United States.
Who is sponsoring the NCT07870395 clinical trial?
NCT07870395 is sponsored by Noah Labs. The trial plans to enroll 450 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.